Table I. Comparison of nucleolar-disrupting activity of various agents and their p53 activation capability.
Agent | Nucleolar disruption | Reference | p53 stabilization | Reference |
---|---|---|---|---|
UV | ✓ | Zatsepina et al. (1989) | ✓ | Pluquet and Hainaut (2001) |
Cis-Pt | ✓ | Jordan and Carmo-Fonseca (1998) | ✓ | Pluquet and Hainaut (2001) |
5-FU | ✓ | Ghoshal and Jacob (1994) | ✓ | Pritchard et al. (1997) |
DRB | ✓ | David-Pfeuty et al. (2001) | ✓ | David-Pfeuty et al. (2001) |
Actinomycin D | ✓ | Haaf and Ward (1996) | ✓ | Andera and Wasylyk (1997) |
α-Amanitin | ✓ | Haaf and Ward (1996) | ✓ | Andera and Wasylyk (1997) |
Camptothecin | ✓ | Buckwalter et al. (1996) | ✓ | Ljungman (2000) |
NTP depletion | ✓ | Grummt and Grummt (1976) | ✓ | Linke et al. (1996) |
Bleomycin | ✓ | Vazquez-Nin et al. (1979) | ✓ | Pluquet and Hainaut (2001) |
Heat shock | ✓ | Y.Liu et al. (1996) | ✓ | Ljungman (2000) |
Hypoxia | ✓ | Yung et al. (1991) | ✓ | Graeber et al. (1994) |
LMB | – | – | ✓ | Freedman and Levine (1998) |
MG132 | – | – | ✓ | Klibanov et al. (2001) |